Olasial Eye Drops contain Olopatadine 0.1% w/v, a selective histamine H1 receptor antagonist with mast cell stabilizing properties, indicated for the treatment of allergic conjunctivitis. Olopatadine effectively alleviates symptoms such as ocular itching, redness, and swelling associated with seasonal allergic conjunctivitis by inhibiting the release of histamine and other inflammatory mediators from mast cells. The formulation is designed for topical ocular administration, providing rapid relief of allergic symptoms with a favorable safety profile. Olasial Eye Drops are suitable for adults and children over the age of 3 years. The recommended dosage is one drop in the affected eye(s) twice daily or as directed by a healthcare professional. Patients should avoid contact lens use during treatment unless lenses are removed prior to instillation and may be reinserted after 15 minutes. Common adverse effects are generally mild and may include transient burning or stinging upon instillation, dry eyes, or a bitter taste. Olasial Eye Drops should be used with caution in patients with hypersensitivity to Olopatadine or any other component of the formulation. Proper hygiene should be maintained to avoid contamination, and the product should not be shared between individuals. Consult a healthcare provider if symptoms persist or worsen.